Japan’s auto industry bleeds $8 billion as U.S. tariffs crush profits. Toyota’s nightmare deepens with another devastating tax on the horizon.
Browsing Category
Business News
75 posts
Trump Greenlights $11B US Steel-Nippon Deal, But Steel Stays American—Permanently
Trump backs $11B US Steel-Nippon mega-deal, but his surprise “golden share” condition transforms how foreign companies can buy American steel forever.
Courts Hit Trump Tariffs Hard—Markets Rally Briefly, Then Spiral Into Economic Uncertainty
Trump tariffs ruled illegal, but market celebration turns to chaos as economic uncertainty spreads. What happens next could change everything.
Biden Declares Trade Emergency, Slaps 10% Tariff to Revive U.S. Industry and Defense
Biden’s drastic 10% global tariff sparks fierce debate. His bold move to save U.S. manufacturing could reshape world trade forever.
JPMorgan Taps NOAA’s Ex-Chief Scientist in Bold Bid to Transform Climate Risk for Clients
JPMorgan poaches NOAA’s brilliant chief scientist to revolutionize climate risk – while Wall Street finally admits money and polar bears don’t mix.
Trump Tariff Idea Risks Wrecking Hollywood’s Rare $15B Global Trade Edge
Trump’s latest tariff gamble could crush Hollywood’s $15B global advantage. Will America’s rare entertainment trade surplus survive this plot twist?
Markets on Edge: Amazon and Apple Stir Investor Debate Amid Tariffs and Tech Turmoil
Even $100B in Apple buybacks can’t save tech giants from market fury as Amazon and Apple face their toughest battle yet.
NVIDIA Faces Wild Week Ahead Amid Tariff Fears and Surging Market Tensions
NVIDIA’s meteoric rise faces brutal disruption as China tariffs threaten $5.5B losses. Can this AI powerhouse dodge the incoming storm?
Massive U.S. Tariffs Could Make Christmas Gifts Scarce and Shockingly Expensive
New U.S. tariffs could transform Christmas into a financial nightmare, with prices soaring 75% and beloved gifts vanishing from shelves. Your holiday budget won’t survive this.
Trump Targets Big Pharma’s Price Game—But Wall Street’s Calm Raises Eyebrows
Despite Trump’s harsh ultimatum to Big Pharma, Wall Street’s calm reaction raises an unsettling question: Who really controls America’s drug prices?